Nasdaq Resumes Trading in Statera Biopharma, Inc.

Rhea-AI Summary

The Nasdaq Stock Market announced that trading in Statera Biopharma resumed on August 26, 2022, at 7:10 a.m. Eastern Time. This follows a halt in trading that occurred a day earlier, on August 25, 2022, at 11:01:52 a.m. Eastern Time. The resumption of trading indicates regulatory clearance, but further details regarding the reasons for the halt or any specific developments regarding Statera Biopharma were not provided in the announcement.

NEW YORK, Aug. 26, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market^® (Nasdaq: NDAQ) announced that trading resumed in Statera Biopharma, Inc. (Nasdaq: STAB) today, August 26, 2022 at 7:10 a.m. Eastern Time. Trading in the company’s stock was halted on August 25, 2022 at 11:01:52 a.m. Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SM on the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Sophia Weiss
Sophia.Weiss@nasdaq.com 

FAQ

What was the reason for the trading halt of Statera Biopharma on August 25, 2022?

The press release did not provide specific reasons for the trading halt of Statera Biopharma on August 25, 2022.

When did trading resume for Statera Biopharma after the halt?

Trading for Statera Biopharma resumed on August 26, 2022, at 7:10 a.m. Eastern Time.

What time was trading halted for Statera Biopharma on August 25, 2022?

Trading in Statera Biopharma was halted on August 25, 2022, at 11:01:52 a.m. Eastern Time.

Where can I find more information about Statera Biopharma's stock?

You can check for additional information under Statera Biopharma's symbol using InfoQuotes on the Nasdaq website.